HealthTronics Announces Exclusive Rights to Distribute BPH Surgical Laser

Christopher B. Schneider, Urology Division COO, said, "The earlyresponse from our urology partners who have used this device has beenextremely positive in comparison to the technology currentlyavailable. They like the front-end firing mode of the laser as well asother unique features not offered on other BPH laser devices. Inaddition to clinical benefits, we believe the economics of the Revolixare more favorable than those associated with the current BPH lasertechnology. The improved economics should benefit our physicianpartners and our growing prostate treatment business."

Kenneth Blunt, M.D., a urologist who is managing the introductionand clinical demonstrations for HealthTronics, stated, "The Revolixproduces a wave length that is absorbed by water rather thanhemoglobin which is believed to provide for more consistentvaporization as compared to a KTP type laser. Also, the Revolix is acontinuous wave laser as opposed to the pulsed method of a holmiumtype laser which some believe is less efficient. This continuous waveis believed to create a cleaner, smoother application to the softtissue or gland."

About HealthTronics, Inc.

HealthTronics provides healthcare services primarily to theUrology community and manufactures and distributes medical devices.The Company also manufactures specialty vehicles used for thetransport of high-technology medical devices and broadcast &communications equipment. For more information, visitwww.healthtronics.com.

Statements by the Company's management during the conference callannounced in this press release that are not strictly historical,including statements regarding plans, objective and future financialperformance, are "forward-looking" statements that are made pursuantto the safe harbor provisions of the Private Securities LitigationReform Act of 1995. Although HealthTronics believes that theexpectations reflected in such forward-looking statements arereasonable, no assurance can be given that the expectations will proveto be correct. Factors that could cause actual results to differmaterially from HealthTronics' expectations include, among others, theexistence of demand for and acceptance of HealthTronics' services,regulatory approvals, economic conditions, the impact of competitionand pricing, financing efforts and other factors described from timeto time in HealthTronics' periodic filings with the Securities andExchange Commission.